Illumina, Inc.
ILMN Healthcare Diagnostics & Research
Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue grew 9.44%, EPS fell 8.05%, free cash flow fell 18.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
Follow ILMN
Illumina, Inc. (ILMN) Free cash flow
Illumina, Inc.'s free cash flow for fiscal 2025 was $931.0M, up 31.3% from $709.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was $931.0M. Over the past ten years it has ranged from −$74.0M (fiscal 2022) to $931.0M (fiscal 2025) — the current reading is the highest in ten years. Free cash flow has risen for 3 consecutive fiscal years. Illumina, Inc. ranks 8th of 52 Diagnostics & Research companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $931.0M | 31.31% |
| FY2024 | $709.0M | 151.42% |
| FY2023 | $282.0M | — |
| FY2022 | −$74.0M | — |
| FY2021 | $337.0M | (62.18%) |
| FY2020 | $891.0M | 5.82% |
| FY2019 | $842.0M | (0.47%) |
| FY2018 | $846.0M | 50.27% |
| FY2017 | $563.0M | 10.83% |
| FY2016 | $508.0M | (21.00%) |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $161.0M | (35.86%) |
| Mar 2026 | $251.0M | (5.64%) |
| Dec 2025 | $266.0M | 5.14% |
| Sep 2025 | $253.0M | 28.43% |
| 42 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| IQV IQVIA Holdings Inc. compare | $2.3B |
| DGX Quest Diagnostics Incorporated compare | $1.3B |
| A Agilent Technologies, Inc. compare | $1.3B |
| IDXX IDEXX Laboratories, Inc. compare | $1.2B |
| LH Labcorp Holdings Inc. compare | $1.2B |
| ILMN Illumina, Inc. | $931.0M |
| MTD Mettler-Toledo International, Inc. compare | $864.0M |
| WAT Waters Corporation compare | $366.6M |
| NTRA Natera, Inc. compare | $84.2M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on ILMN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement